JSM 2011 Online Program
The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Activity Details
|
|||
580 * | Wed, 8/3/2011, 2:00 PM - 3:50 PM | CC-D237 | |
Sample Size in Clinical Trials — Contributed Papers | |||
Biopharmaceutical Section | |||
Chair(s): Eric Yaw Frimpong, U.S. Food and Drug Administration | |||
2:05 PM | Optimal Sample Size and Go/No-Go Decision Based on Probability of Success — Kaihong Jiang, sanofi-aventis | ||
2:20 PM | R Functions for Sample Size and Probability Calculations for Assessing Consistency of Treatment Effects in Multi-Regional Clinical Trials — Mingyu Li, Celgene Corporation ; Hui Quan, sanofi-aventis ; Joshua Chen, Merck & Co., Inc. ; Yoko Tanaka, Eli Lilly and Company ; Peter Ouyang, Celgene Corporation ; Xiaolong Luo, Celgene Corporation ; Gang Li, Johnson & Johnson Pharmaceutical R&D, LLC | ||
2:35 PM | One-Sample Proportion Testing Procedures for Hypothesis of Inequality — Wayne Zhong, Octagon Research Solutions, Inc. ; Bob Zhong, Johnson & Johnson Pharmaceutical R&D, LLC | ||
2:50 PM | Sample Size Determination for Cut Point of Immunogenicity Assays — Lanju Zhang, MedImmune, Inc. ; Jianchun Zhang, MedImmune, Inc. ; Harry Yang, MedImmune, Inc. | ||
3:05 PM | Power Calculation in Clinical Trials — Lingling Han, Merck & Co., Inc. | ||
3:35 PM | Floor Discussion |
2011 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.